Early research (Phase 1)Study completedNCT01317745What this trial is testingH5N1 Mix and Match With MF59Who this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT01379937What this trial is testingEvaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in ChildrenWho this might be right forInfluenza GlaxoSmithKline 520
Testing effectiveness (Phase 2)Study completedNCT02719743What this trial is testingA Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of AgeWho this might be right forInfluenza GlaxoSmithKline 185
Large-scale testing (Phase 3)Study completedNCT01382329What this trial is testingH5N1 Vaccine Study in Japanese AdultsWho this might be right forH5N1 Influenza Alachua Government Services, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT01910519What this trial is testingSystems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)Who this might be right forInfluenza A Virus, H5N1 Subtype National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00812019What this trial is testingDose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)Who this might be right forInfluenza Seqirus 753
Testing effectiveness (Phase 2)Study completedNCT01353534What this trial is testingOpen-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 VaccineWho this might be right forHealthy Intercell USA, Inc. 276
Testing effectiveness (Phase 2)Study completedNCT00415129What this trial is testingSafety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the ElderlyWho this might be right forInfluenzaOrthomyxoviridae Infections Sanofi Pasteur, a Sanofi Company 600
Early research (Phase 1)Study completedNCT00240903What this trial is testingRevaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) VaccineWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 37
Testing effectiveness (Phase 2)Study completedNCT00115986What this trial is testingA/H5N1in Adult - AventisWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 452
Testing effectiveness (Phase 2)Study completedNCT00537524What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 YearsWho this might be right forProphylaxis of Avian Influenza Novartis Vaccines 471
Not applicableStudy completedNCT02743676What this trial is testingA Retrospective, Observational Registry of Participants With Avian Influenza InfectionWho this might be right forInfluenza Hoffmann-La Roche 648
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128615What this trial is testingA Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)Who this might be right forInfluenza A AstraZeneca 405
Testing effectiveness (Phase 2)Study completedNCT00491985What this trial is testingSafety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in ChildrenWho this might be right forInfluenzaOrthomyxoviridae InfectionsInfluenza A Virus Infection Sanofi Pasteur, a Sanofi Company 240
Early research (Phase 1)Study completedNCT02206464What this trial is testingH7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...Who this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00462215What this trial is testingPhase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)Who this might be right forInfluenza Alachua Government Services, Inc. 550
Large-scale testing (Phase 3)Study completedNCT00434733What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly SubjectsWho this might be right forInfluenza Novartis 4,400
Early research (Phase 1)Study completedNCT00309647What this trial is testingStudy to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of AgeWho this might be right forInfluenza GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT00719043What this trial is testingImmunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 YearsWho this might be right forInfluenza GlaxoSmithKline 841
Early research (Phase 1)Study completedNCT01258062What this trial is testingStudy to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young AdultsWho this might be right forPhase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine Alachua Government Services, Inc. 7